Be the first person to write a business review for Burns, Philp & Company Pty Limited

Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $950 million under management. Burrill's technical and venture investing competence spans the entire spectrum of life sciences. The expertise of the firm's investment team, strategic partners and Advisory Boards is unparalleled in depth and breadth. In addition, Burrill is a leader in life science strategic partnering, an invaluable practice to build value in portfolio companies and to accelerate their growth and development.Burrill is also the sponsor and facilitator of several leading annual industry conferences and publishes the seminal annual report on the state of the biotechnology industry. This combination of resources and capabilities has helped Burrill develop a unique and highly effective platform for finding and making outstanding life science investments.G. Steven Burrill founded Burrill & Company as a logical extension of his 40-year involvement in the growth and prosperity of the biotechnology industry. Mr. Burrill has been an active advisor and catalyst in some of the industry's most notable companies and transactions. Mr. Burrill's close involvement and respected position within the industry has positioned the firm as a prominent deal-maker and facilitator of industry partnerships and alliances, all of which fosters a robust deal flow. Further contributing to this deal flow are: the scientific and business networks of its investment team; the Advisory Boards; the strategic and financial network of its limited partners; and the close relationships developed with numerous life science companies and management as a result of Burrill's visibility, reputation, and the firm's partnering and alliance work.

Cabot Square Capital was founded in 1996. Cabot Square Capital invests capital in small and mid-sized companies in growing markets in the UK and Western Europe. It also specializes in startup business and companies in a state of expansion or turnaround. The firm currently offers customers its Cabot Square Capital Partners II, with some $200 million ($320 million) of committed capital, and its third fund, CS Capital Partners III, with approximately $300 million ($480 million) of committed capital. The firm typically takes majority control positions in its acquisitions and sees its role as a value-added partner.

Calera Capital was founded in 1991 and is headquartered in San Francisco, California. Calera Capital is a private equity firm specializing in investments in public or private middle market companies, family-controlled enterprises, and corporate divestitures. It seeks to invest in buyouts and PIPES. The firm invests across a wide variety of industries, including building and forest products, food and consumer products, healthcare and medical devices, distribution and business services, specialty packaging, financial services, electrical products and industrial manufacturing. The firm considers investments in corporate spin-offs, take-private transactions, leveraged re-capitalizations of privately held companies, restructurings, and companies seeking capital to facilitate growth or acquisitions. It focuses on companies with enterprise values of up to $1 billion, typically deploying a minimum of $75 million in each transaction.

Camellia Plc, through its subsidiaries, operates in agriculture and horticulture, engineering, food storage and distribution, insurance, pharmaceuticals, and private banking and financial services businesses. Its agriculture and horticulture business includes production of tea, edible nuts, avocados, rubber, soya, wheat, citrus products, wine grapes, table grapes, and other horticultural produce; and general farming operations. The company’s engineering business comprises the provision of metal finishing, fabrication, precision engineering, and heat treatment services primarily for the aerospace, and oil and gas industries. It has operations in the United Kingdom, Continental Europe, India, Kenya, Malawi, Bangladesh, North America, Bermuda, South Africa, and South America.

Founded in 1987, Canaan closed its eighth fund in 2008. Notable past investments include Acme Packet, Amicus Therapeutics, DoubleClick, and Match.com. Canaan Management (alslo known as Canaan Partners) is a venture capital firm that invests primarily in early-stage technology and health care companies, with a focus on digital media, mobile communications, enterprise software, clean technology, biopharmaceuticals, medical devices, and diagnostics. Canaan company typically invests $1 million to $20 million per transaction and has approximately $3 billion in capital under management.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.